Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Skf-83566 (hydrobromide) | 99295-33-7 | MFCD04975449 | 99.8% | 332.23 g/mol | C17H18BrNO | 10 MG
SDP

Catalog No. 5000246658
Encompass_Preferred

SKF-83566 (hydrobromide) is a small-molecule research reagent that acts as a D1-like dopamine receptor (D1/D5) antagonist. It is blood-brain barrier permeable and provided at high analytical purity for use in in vitro and in vivo pharmacology studies.

  • D1-like dopamine receptor antagonist suitable for pharmacological research.
  • Blood-brain barrier permeable, enabling central nervous system studies.
  • High analytical purity (~99.8%) for reproducible results.
  • Molecular formula C17H18BrNO; molecular weight 332.23 g/mol.
  • Soluble in DMSO (approx. 33.33 mg/mL); ultrasonic agitation recommended.

Catalog No. 50-002-46658 Supplier Medchemexpress LLC Supplier No. HY103430A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SKF-83566 (hydrobromide) is a small-molecule research reagent that acts as a D1-like dopamine receptor (D1/D5) antagonist. It is blood-brain barrier permeable and provided at high analytical purity for use in in vitro and in vivo pharmacology studies.

  • D1-like dopamine receptor antagonist suitable for pharmacological research.
  • Blood-brain barrier permeable, enabling central nervous system studies.
  • High analytical purity (~99.8%) for reproducible results.
  • Molecular formula C17H18BrNO; molecular weight 332.23 g/mol.
  • Soluble in DMSO (approx. 33.33 mg/mL); ultrasonic agitation recommended.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.